Kevin Kotler, 10% Owner at PROGENICS PHARMACEUTICALS INC (PGNX), bought 1,625,436 shares at $4.48 ($7.5M) on 2014-07-17, disclosed to the SEC on 2014-07-23.
Open-market purchase of $7.5M PGNX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.48 | 411,693 | $1.8M | 24.7% |
| 2 | $4.48 | 436,884 | $2.0M | 26.2% |
| 3 | $4.73 | 388,200 | $1.8M | 24.6% |
| 4 | $4.73 | 388,659 | $1.8M | 24.6% |
| Total | $4.60 avg | 1,625,436 | $7.5M | 100% |
| Filing → |
| BDSI | SELL | 2019-04-15 | $10.0M | — | Filing → |
| NVLN | SELL | 2018-12-27 | $483K | — | Filing → |
| REPH | SELL | 2017-12-22 | $750K | — | Filing → |